在iPSC衍生的移植和猪心肌之间界面的光学映射表明了潜在的心律失常机制
Bijay Guragain1, Hanyu Zhang1, Yuhua Wei1
1Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.
NPJ Regenerative medicine
|November 3, 2025
概括
工程心脏组织移植可能会导致心律失常,原因是导电缓慢和电桥有限. 这些问题可能会随着移植物成熟并与宿主心脏组织集成而得到解决.
科学领域:
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
- 心脏电生理学 心脏电生理学
背景情况:
- 心肌梗塞 (MI) 仍然是心力衰竭的主要原因.
- 心脏组织工程为心脏中风提供了一个有前途的再生方法.
- 评估心脏移植的电整合和心律失常潜力对于临床转换至关重要.
研究的目的:
- 在猪模型中研究工程心脏组织移植后潜在的心律失常机制.
- 在植入后一周,在细胞层面评估电传播和移植宿主集成.
主要方法:
- 使用高分辨率光学映射 (~50μm) 来绘制心脏切片中的电传播图像.
- 工程心脏球体被植入到诱导肌肉心脏梗塞的边界区域,在免疫抑制的猪.
- 组织学分析评估了移植-宿主接口特征,包括连接素-43的表达和组织对齐.
主要成果:
- 观察到从宿主到移植的电传播,电桥稀疏 (毫米间距).
- 与宿主组织相比,移植体内的传导速度明显较慢 (约4倍).
- 虽然一个植入物表现出自发的打击,但没有观察到向宿主传播;没有诱导重新进入,但由于传导缓慢存在潜力.
结论:
- 工程心脏组织移植显示,在植入后一周内,有可能出现重新进入或焦点心律失常.
- 稀疏的电气合和缓慢的移植导电是导致心律失常的关键因素.
- 这些电气异常可能是短暂的,可能通过移植成熟和改进的移植主界面集成来解决.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...


